intellectual property rights

Printer-friendly version

Chinese companies are increasingly laying claim to patents, even if they were not the first to develop the broader technology.

Printer-friendly version

Canada’s lagging intellectual property (IP) protections for pharmaceutical innovators are a key issue to be settled in the Comprehensive Economic and Trade Agreement (CETA) negotiations with the European Union. They may also play a role in upcoming negotiations for the multi-country Trans-Pacific Partnership (TPP).